| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41120a1480fac7dff510d3d8b96d040b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7c24d3e21e4d435d3711519ad147e4e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2009-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d69d0d5929a61432b6ffe84b95faa308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af107fd3bb7f21c2f4eb31560655ac34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a547013b0c18690aef04388df4f2a2fe |
| publicationDate |
2011-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2331091-A1 |
| titleOfInvention |
Pharmaceutical combination of 1-(2-tetrahydrofuryl)-5-fluorouracil and caffeic acid phenethyl ester for oral treating of tumors |
| abstract |
The present invention provides pharmaceutical combination of phenolic compound, such as caffeic acid phenethyl ester and cancer chemotherapeutic agent, such as 1-(2-tetrahydrofuryl)-5-fluorouracil. In one embodiment of the present invention, pharmaceutical combination of caffeic acid phenethyl ester and 1-(2-tetrahydrofuryl)-5-fluorouracil can be used for inhibition of tumor metastases. |
| priorityDate |
2008-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |